CING (Cingulate Inc. Common Stock) Stock Analysis - Insider Trades
Cingulate Inc. Common Stock (CING) is a publicly traded Healthcare sector company. As of May 21, 2026, CING trades at $4.64 with a market cap of $59.48M and a P/E ratio of -1.07. CING moved +5.92% today. Year to date, CING is -2.53%; over the trailing twelve months it is +27.90%. Its 52-week range spans $3.02 to $11.89. Analyst consensus is strong buy with an average price target of $25.67. Rallies surfaces CING's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading CING stock inside the company?
Recent CING insider activity includes Werth Peter J. bought 19.45K, Callahan Jennifer L. bought 4.86K, Brams Matthew bought 1.95K, Schaffer Shane J. bought 6.81K, and Myers Laurie sold 202. Rallies tracks insider transaction dates, shares, prices, and estimated values.
CING Key Metrics
Key financial metrics for CING
Metric
Value
Price
$4.64
Market Cap
$59.48M
P/E Ratio
-1.07
EPS
$-4.23
Dividend Yield
0.00%
52-Week High
$11.89
52-Week Low
$3.02
Volume
2.69K
Avg Volume
0
Revenue (TTM)
$-1.79M
Net Income
$-27.91M
Gross Margin
0.00%
Recent CING Insider Trades
Werth Peter J. bought 19.45K (~$98.05K) on Feb 6, 2026.
Callahan Jennifer L. bought 4.86K (~$24.51K) on Feb 6, 2026.
Brams Matthew bought 1.95K (~$9.81K) on Feb 6, 2026.
Schaffer Shane J. bought 6.81K (~$34.32K) on Feb 6, 2026.
Recent CING insider activity includes Werth Peter J. bought 19.45K, Callahan Jennifer L. bought 4.86K, Brams Matthew bought 1.95K, Schaffer Shane J. bought 6.81K, and Myers Laurie sold 202. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CING?
Yes. Rallies tracks CING insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CING research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CING. It does not provide personalized investment advice.